[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Wound Care Biologics Market Size Study Forecasts By Wound Type (Ulcers, Surgical and Traumatic Wounds, Burns) By End User (Hospitals, ASCs, Burn Centers and Wound Clinics) and Regional Forecasts 2017-2025

June 2018 | 120 pages | ID: GF157B3F6EDEN
Bizwit Research & Consulting LLP

US$ 3,150.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Wound Care Biologics Market to reach USD 2.9 billion by 2025.

Global Wound Care Biologics Market valued approximately USD 1.2 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.1% over the forecast period 2017-2025. The driving factor for the wound biological market is the rising prevalence of chronic wounds such as diabetic foot ulcers, leg ulcers, as well as; increasing incidents of burns; and growing number of fire accidents. and increasing harmful accidents involving use of acid, skin diseases, and surge in the number of body surgeries are likely to pump-up the global wound biologics market during the forecast period.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Wound Type
  • Ulcers
  • Surgical and Traumatic Wounds
  • Burns
By End User
  • Hospitals
  • ASCs
  • Burn Centers and Wound Clinics
  • By Regions:
    • North America
    • U.S.
    • Canada
    • Europe
    • UK
    • Germany
    • Asia Pacific
    • China
    • India
    • Japan
    • Rest of the World
    Furthermore, years considered for the study are as follows:

    Historical year – 2015
    Base year – 2016
    Forecast period – 2017 to 2025

    Some of the key manufacturers involved in the Smith & Nephew plc, Integra Life Sciences Corporation, B. Braun Melsungen AG, Mцlnlycke Health Care AB, 3M Healthcare, Ethicon, Inc. (Johnson & Johnson), Hill-Rom Holdings, Inc., Cardinal Health, Acelity L.P., Inc., ConvaTec Inc., BSN medical (Svenska Cellulosa Aktiebolaget SCA), Coloplast Group. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

    Target Audience of the Global Wound Care Biologics in Market Study:
    • Key Consulting Companies & Advisors
    • Large, medium-sized, and small enterprises
    • Venture capitalists
    • Value-Added Resellers (VARs)
    • Third-party knowledge providers
    • Investment bankers
    • Investors
    CHAPTER 1. GLOBAL WOUND CARE BIOLOGICS MARKET DEFINITION AND SCOPE

    1.1. Research Objective
    1.2. Market Definition
    1.3. Scope of The Study
    1.4. Years Considered for The Study
    1.5. Currency Conversion Rates
    1.6. Report Limitation

    CHAPTER 2. RESEARCH METHODOLOGY

    2.1. Research Process
      2.1.1. Data Mining
      2.1.2. Analysis
      2.1.3. Market Estimation
      2.1.4. Validation
      2.1.5. Publishing
    2.2. Research Assumption

    CHAPTER 3. EXECUTIVE SUMMARY

    3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
    3.2. Key Trends

    CHAPTER 4. GLOBAL WOUND CARE BIOLOGICS MARKET DYNAMICS

    4.1. Growth Prospects
      4.1.1. Drivers
      4.1.2. Restraints
      4.1.3. Opportunities
    4.2. Industry Analysis
      4.2.1. Porter’s 5 Force Model
      4.2.2. PEST Analysis
      4.2.3. Value Chain Analysis
    4.3. Analyst Recommendation & Conclusion

    CHAPTER 5. GLOBAL WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE

    5.1. Market Snapshot
    5.2. Market Performance - Potential Model
    5.3. Global Wound Care Biologics Market, Sub Segment Analysis
      5.3.1. Ulcers
        5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
      5.3.2. Surgical & Traumatic Wounds
        5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
      5.3.3. Burns
        5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

    CHAPTER 6. GLOBAL WOUND CARE BIOLOGICS MARKET, BY END-USE

    7.1. Market Snapshot
    7.2. Market Performance - Potential Model
    7.3. Global Wound Care Biologics Market, Sub Segment Analysis
      6.1.1. Hospitals
        6.1.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        6.1.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
      6.1.2. Ambulatory Surgical Centres(ASC)
        6.1.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        6.1.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
      6.1.3. Burn Centres and Wound Clinics
        6.1.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        6.1.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

    CHAPTER 7. GLOBAL WOUND CARE BIOLOGICS MARKET, BY REGIONAL ANALYSIS

    7.1. Wound Care Biologics Market, Regional Market Snapshot (2015-2025)
    7.2. North America Wound Care Biologics Market Snapshot
      7.2.1. U.S.
        7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        7.2.1.2. Wound Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
        7.2.1.3. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      7.2.2. Canada
        7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        7.2.2.2. Wound Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
        7.2.2.3. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.3. Europe Wound Care Biologics Market Snapshot
      7.3.1. U.K.
        7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        7.3.1.2. Wound Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
        7.3.1.3. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      7.3.2. Germany
        7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        7.3.2.2. Wound Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
        7.3.2.3. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      7.3.3. France
        7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        7.3.3.2. Wound Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
        7.3.3.3. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      7.3.4. Rest of Europe
        7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        7.3.4.2. Wound Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
        7.3.4.3. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.4. Asia Wound Care Biologics Market Snapshot
      7.4.1. China
        7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        7.4.1.2. Wound Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
        7.4.1.3. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      7.4.2. India
        7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        7.4.2.2. Wound Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
        7.4.2.3. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      7.4.3. Japan
        7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        7.4.3.2. Wound Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
        7.4.3.3. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      7.4.4. Rest of Asia Pacific
        7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        7.4.4.2. Wound Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
        7.4.4.3. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.5. Rest of The World
      7.5.1. South America
        7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        7.5.1.2. Wound Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
        7.5.1.3. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      7.5.2. Middle East and Africa
        7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        7.5.2.2. Wound Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
        7.5.2.3. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

    CHAPTER 8. COMPETITIVE INTELLIGENCE

    8.1. Company Market Share (Subject to Data Availability)
    8.2. Top Market Strategies
    8.3. Company Profiles
      8.3.1. Smith & Nephew plc.
        8.3.1.1. Overview
        8.3.1.2. Financial (Subject to Data Availability)
        8.3.1.3. Product Summary
        8.3.1.4. Recent Developments
      8.3.2. Integra Life Sciences Corporation
      8.3.3. B. Braun Melsungen AG
      8.3.4. Mцlnlycke Health Care AB
      8.3.5. 3M Healthcare
      8.3.6. Ethicon Inc.
      8.3.7. , Hill-Rom Holdings, Inc.
      8.3.8. , Cardinal Health,
      8.3.9. Acelity L.P., Inc.,
      8.3.10. ConvaTec Inc.,
      8.3.11. BSN medical (Svenska Cellulosa Aktiebolaget SCA),
      8.3.12. Coloplast Group.


    More Publications